Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8528895 | European Journal of Pharmacology | 2018 | 14 Pages |
Abstract
Fesoterodine's pharmacological profile is optimal for the treatment of overactive bladder. It is now recognized as one of the leading first-line treatment for this indication.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Xavier Gamé, Benoit Peyronnet, Jean-Nicolas Cornu,